✦ LIBER ✦

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

✍ Scribed by Perren, Timothy J.; Swart, Ann Marie; Pfisterer, Jacobus; Ledermann, Jonathan A.; Pujade-Lauraine, Eric; Kristensen, Gunnar; Carey, Mark S.; Beale, Philip; Cervantes, Andrés; Kurzeder, Christian; Bois, Andreas du; Sehouli, Jalid; Kimmig, Rainer; Stähle, Anne; Collinson, Fiona; Essapen, Sharadah; Gourley, Charlie; Lortholary, Alain; Selle, Frédéric; Mirza, Mansoor R.; Leminen, Arto; Plante, Marie; Stark, Dan; Qian, Wendi; Parmar, Mahesh K.B.; Oza, Amit M.

Book ID: 119959805
Publisher: Massachusetts Medical Society
Year: 2011
Tongue: English
Weight: 777 KB
Volume: 365
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1103799

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy in Patient Subgroups in OCEANS,

Efficacy in Patient Subgroups in OCEANS, a Randomized, Double-blinded, Placebo-controlled, Phase 3 Trial of Chemotherapy ± Bevacizumab in Patients with Platinum-sensitive Recurrent Epithelial Ovarian (OC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)

✍ C. Aghajanian; S.V. Blank; B. Goff; P.L. Judson; S. Makhija; S.K. Sharma; L.R. N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Late-Breaking Abstract 5: Results from a

Late-Breaking Abstract 5: Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC)

✍ C. Aghajanian; S. Blank; B. Goff; P. Judson; L. Nycum; M. Sovak; J. Yi; A. Husai 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Bevacizumab in the treatment of ovarian

Bevacizumab in the treatment of ovarian cancer: a meta-analysis from four phase III randomized controlled trials

✍ Ye, Qing; Chen, Hong-Lin 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 608 KB

Combination of irinotecan and bevacizuma

Combination of irinotecan and bevacizumab for heavily pretreated recur- rent ovarian cancer: A phase II trial

✍ Ling, H.; Muggia, F.; Speyer, J.; Curtin, J.; Blank, S.; Boyd, L.; Pothuri, B.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II Trial of Bevacizumab in Persist

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB

Selected Phase III Trials in Ovarian Can

Selected Phase III Trials in Ovarian Cancer

✍ J. Tate Thigpen 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 421 KB